CCR7 regulates cell migration and invasion through MAPKs in metastatic squamous cell carcinoma of head and neck

International Journal of Oncology

Volumn 45, Issue 6, 2014, Pages 2502-2510

  Liu, Fa Yu ^a   Safdar, Jawad ^a   Li, Zhen Ning ^a   Fang, Qi Gen ^a   Zhang, Xu ^a   Xu, Zhong Fei ^a   Sun, Chang Fu ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

CCR7; ERK1 2; JNK; MAPK; Squamous cancer cells of head and neck

Indexed keywords

CADHERIN; CCR7 PROTEIN, HUMAN; CHEMOKINE RECEPTOR CCR7; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4;

ADULT; AGED; BIOSYNTHESIS; CELL MOTION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HEAD AND NECK TUMOR; HUMAN; LYMPH NODE METASTASIS; MALE; MIDDLE AGED; PATHOLOGY; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

ADULT; AGED; CADHERINS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL MOVEMENT; CHEMOKINE CCL19; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; MALE; MAP KINASE KINASE 4; MAP KINASE SIGNALING SYSTEM; MIDDLE AGED; MITOGEN-ACTIVATED PROTEIN KINASE 3; RECEPTORS, CCR7; SIGNAL TRANSDUCTION;

EID: 84907691718     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2014.2674     Document Type: Article

References (46)

1. Greenlee RT, Hill-Harmon MB, Murray T and Thun M: Cancer statistics, 2001. CA Cancer J Clin 51:15-36, 2001.
2. Butcher EC, Williams M, Youngman K, Rott L and Briskin M: Lymphocyte trafficking and regional immunity. Adv Immunol 72:209-253, 1999.
3. Campbell JJ and Butcher EC: Chemokines in tissue-specific and microenvironment-specific lymphocyte homing. Curr Opin Immunol 12:336-341, 2000.
4. Morales J, Homey B, Vicari AP, et al: CTACK, a skin-associated chemokine that preferentially attracts skin-homing memory T cells. Proc Natl Acad Sci USA 96:14470-14475, 1999.
5. Zlotnik A and Yoshie O: Chemokines: a new classification system and their role in immunity. Immunity 12:121-127, 2000.
6. Mburu YK, Abe K, Ferris LK, Sarkar SN and Ferris RL: Human β-defensin 3 promotes NF-κB-mediated CCR7 expression and anti-apoptotic signals in squamous cell carcinoma of the head and neck. Carcinogenesis 32:168-174, 2011.
7. Nagira M, Imai T, Yoshida R, et al: A lymphocyte-specific CC chemokine, secondary lymphoid tissue chemokine (SLC), is a highly efficient chemoattractant for B cells and activated T cells. Eur J Immunol 28:1516-1523, 1998.
8. Iijima N, Yanagawa Y, Clingan JM and Onoé K: CCR7-mediated c-Jun. N-terminal kinase activation regulates cell migration in mature dendritic cells. Int Immunol 17:1201-1212, 2005.
9. Emmett MS, Lanati S, Dunn DB, Stone OA and Bates DO: CCR7 mediates directed growth of melanomas towards lymphatics. Microcirculation 18:172-182, 2011.
10. Ding Y, Shimada Y, Maeda M, et al: Association of CC chemokine receptor 7 with lymph node metastasis of esophageal squamous cell carcinoma. Clin Cancer Res 9:3406-3412, 2003.
11. Takanami I: Overexpression of CCR7 mRNA in nonsmall cell lung cancer: correlation with lymph node metastasis. Int J Cancer 105:186-189, 2003.
12. Murakami T, Cardones AR and Hwang ST: Chemokine receptors and melanoma metastasis. J Dermatol Sci 36:71-78, 2004.
13. Gunther K, Leier J, Henning G, et al: Prediction of lymph node metastasis in colorectal carcinoma by expression of chemokine receptor CCR7. Int J Cancer 116:726-733, 2005.
14. Cabioglu N, Yazici MS, Arun B, et al: CCR7 and CXCR4 as novel biomarkers predicting axillary lymph node metastasis in T1 breast cancer. Clin Cancer Res 11:5686-5693, 2005.
15. Schimanski CC, Bahre R, Gockel I, et al: Chemokine receptor CCR7 enhances intrahepatic and lymphatic dissemination of human hepatocellular cancer. Oncol Rep 16:109-113, 2006.
16. Zhao ZJ, Li P, Liu FY, Sun LY and Sun CF: PKCα take part in CCR7/NF-κB autocrine signaling loop in CCR7-positive squamous cell carcinoma of head and neck. Mol Cell Biochem 357:181-187, 2011.
17. Zhao ZJ, Liu FY, Li P, Ding X, Zong ZH and Sun CF: CCL19-induced chemokine receptor 7 activates the phosphoinositide-3 kinase-mediated invasive pathway through Cdc42 in metastatic squamous cell carcinoma of the head and neck. Oncol Rep 25:729-737, 2011.
18. Li P, Zhao ZJ, Liu FY, et al: The chemokine receptor 7 regulates cell adhesion and migration via betal integrin in metastatic squamous cell carcinoma of the head and neck. Oncol Rep 24:989-995, 2010.
19. Li P, Liu F, Sun L, et al: Chemokine receptor 7 promotes cell migration and adhesion in metastatic squamous cell carcinoma of the head and neck by activating integrin αvß3. Int J Mol Med 27:679-687, 2011.
20. Liu FY, Zhao ZJ, Li P, Ding X, Zong ZH and Sun CF: Mammalian target of rapamycin (mTOR) is involved in the survival of cells mediated by chemokine receptor 7 through PI3K/Akt in metastatic squamous cell carcinoma of the head and neck. Br J Oral Maxillofac Surg 48:291-296, 2010.
21. Liu FY, Zhao ZJ, Li P, Ding X and Sun CF: Effect of rapamycin combined with cisplatin on head and neck squamous cancer cells regulated by CCL19. Zhonghua Kou Qiang Yi Xue Za Zhi 46:197-200, 2011 (In Chinese).
22. Liu FY, Zhao ZJ, Li P, Ding X and Sun CF: The effect of CCL19 on the viability of head and neck squamous cancer cells. Shanghai Kou Qiang Yi Xue 19:158-161, 2010 (In Chinese).
23. Liu FY, Zhao ZJ, Li P, et al: NF-κB participates in chemokine receptor 7-mediated cell survival in metastatic squamous cell carcinoma of the head and neck. Oncol Rep 25:383-391, 2011.
24. Liu FY, Zhao ZJ, Huang SH and Sun CF: Role of PDTC in CCL19 regulating the activity of human head and neck squamous cancer cells. J Chin Med Univ 37:847-849, 2008 (In Chinese).
25. Thelen M: Dancing to the tune of chemokines. Nat Immunol 2:129-134, 2001.
26. Ganju RK, Brubaker SA, Meyer J, et al: The alpha-chemokine, stromal cell-derived factor-lalpha, binds to the transmembrane G-protein-coupled CXCR-4 receptor and activates multiple signal transduction pathways. J Biol Chem 273:23169-23175, 1998.
27. Ganju RK, Dutt P, Wu L, et al: Beta-chemokine receptor CCR5 signals via the novel tyrosine kinase RAFTK. Blood 91:791-797, 1998.
28. Wong MM and Fish EN: Chemokines: attractive mediators of the immune response. Semin Immunol 15:5-14, 2003.
29. Huang P, Han J and Hui L: MAPK signaling in inflammation-associated cancer development. Protein Cell 1:218-226, 2010.
30. Klemke RL, Cai S, Giannini AL, Gallagher PJ, de Lanerolle P and Cheresh DA: Regulation of cell motility by mitogen-activated protein kinase. J Cell Biol 137:481-492, 1997.
31. Huang C, Rajfur Z, Borchers C, Schaller MD and Jacobson K: JNK phosphorylates paxillin and regulates cell migration. Nature 424:219-223, 2003.
32. Wang H, Wu C, Wan S, Zhang H, Zhou S and Liu G: Shikonin attenuates lung cancer cell adhesion to extracellular matrix and metastasis by inhibiting integrin ßl expression and the ERK1/2 signaling pathway. Toxicology 308:104-112, 2013.
33. Wang J, Zhang X, Thomas SM, et al: Chemokine receptor 7 activates phosphoinositide-3 kinase-mediated invasive and prosurvival pathways in head and neck cancer cells independent of EGFR. Oncogene 24:5897-5904, 2005.
34. Mburu YK, Wang J, Wood MA, Walker WH and Ferris RL: CCR7 mediates inflammation-associated tumor progression. Immunol Res 36:61-72, 2006.
35. Liotta LA, Steeg PS and Stetler-Stevenson WG: Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 64:327-336, 1991.
36. Ngo VN, Tang HL and Cyster JG: Epstein-Barr virus-induced molecule 1 ligand chemokine is expressed by dendritic cells in lymphoid tissues and strongly attracts naive T cells and activated B cells. J Exp Med 188:181-191, 1998.
37. Johnson GL: Defining MAPK interactomes. ACS Chem Biol 6:18-20, 2011.
38. Riol-Blanco L, Sánchez-Sánchez N, Torres A, et al: The chemokine receptor CCR7 activates in dendritic cells two signaling modules that independently regulate chemotaxis and migratory speed. J Immunol 174:4070-4080, 2005.
39. Shannon LA, Calloway PA, Welch TP and Vines CM: CCR7/CCL21 migration on fibronectin is mediated by phospholipase Cgammal and ERK1/2 in primary T lymphocytes. J Biol Chem 285:38781-38787, 2010.
40. Redondo-Muñoz J, José Terol M, García-Marco JA, García-Pardo A: Matrix metalloproteinase-9 is up-regulated by CCL21/CCR7 interaction via extracellular signa-lregulated kinase-1/2 signaling and is involved in CCL21-driven B-cell chronic lymphocytic leukemia cell invasion and migration. Blood 111:383-386, 2008.
41. Johnson GL, Dohlman HG and Graves LM: MAPK kinase kinases (MKKKs) as a target class for small-molecule inhibition to modulate signaling networks and gene expression. Curr Opin Chem Biol 9:325-331, 2005.
42. Takayama T, Shiozaki H, Shibamoto S, et al: Beta-catenin expression in human cancers. Am J Pathol 148:39-46, 1996.
43. Savagner P: Leaving the neighborhood: molecular mechanisms involved during epithelial-mesenchymal transition. Bioessays 23:912-923, 2001.
44. Behrens J: Cadherins and catenins: role in signal transduction and tumor progression. Cancer Metastasis Rev 18:15-30, 1999.
45. Cheng JC, Klausen C and Leung PC: Hydrogen peroxide mediates EGF-induced down-regulation of E-cadherin expression via p38 MAPK and snail in human ovarian cancer cells. Mol Endocrinol 24:1569-1580, 2010.
46. Chen XF, Zhang HJ, Wang HB, et al: Transforming growth factor-ßl induces epithelial-to-mesenchymal transition in human lung cancer cells via PI3K/Akt and MEK/Erkl/2 signaling pathways. Mol Biol Rep 39:3549-3556, 2011.